We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$2.05B
AUM Growth
+$4.1M
Cap. Flow
+$55.1M
Cap. Flow %
2.69%
Top 10 Hldgs %
6.78%
Holding
2,312
New
444
Increased
666
Reduced
682
Closed
516

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.7M
2
MA icon
Mastercard
MA
+$9.24M
3
DIS icon
Walt Disney
DIS
+$8.67M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.43M
5
ADBE icon
Adobe
ADBE
+$8.31M

Sector Composition

Rank Sector Weight
1 Technology 15.67%
2 Healthcare 15.06%
3 Consumer Discretionary 13.46%
4 Industrials 11.68%
5 Financials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
251
PepsiCo
PEP
$190B
$2.14M 0.1%
22,942
-20,617
-47% -$1.97M
HUBS icon
252
HubSpot
HUBS
$12.2B
$2.13M 0.1%
+42,880
New +$1.97M
ARW icon
253
Arrow Electronics
ARW
$11.1B
$2.12M 0.1%
38,039
+25,089
+194% +$1.52M
FMC icon
254
FMC
FMC
$1.34B
$2.11M 0.1%
46,256
+27,711
+149% +$1.38M
RSPP
255
DELISTED
RSP Permian, Inc.
RSPP
$2.1M 0.1%
74,818
+51,428
+220% +$1.46M
BLUE
256
DELISTED
bluebird bio
BLUE
$2.1M 0.1%
962
-6
-0.6% -$12.2K
HDS
257
DELISTED
HD Supply Holdings, Inc.
HDS
$2.09M 0.1%
59,426
+42,912
+260% +$1.43M
TEL icon
258
TE Connectivity
TEL
$59.6B
$2.09M 0.1%
32,471
-42,266
-57% -$2.92M
WLK icon
259
Westlake Corp
WLK
$9.03B
$2.08M 0.1%
30,339
+26,567
+704% +$1.93M
MDVN
260
DELISTED
MEDIVATION, INC.
MDVN
$2.06M 0.1%
36,172
+24,682
+215% +$1.52M
OII icon
261
Oceaneering
OII
$4.86B
$2.06M 0.1%
44,238
+37,586
+565% +$1.98M
CLVS
262
DELISTED
Clovis Oncology, Inc.
CLVS
$2.06M 0.1%
23,382
-2,165
-8% -$185K
ACAD icon
263
Acadia Pharmaceuticals
ACAD
$4.43B
$2.05M 0.1%
49,000
+48,700
+16,233% +$1.88M
HQY icon
264
HealthEquity
HQY
$8.41B
$2.05M 0.1%
64,018
+32,652
+104% +$877K
PG icon
265
Procter & Gamble
PG
$336B
$2.05M 0.1%
26,181
-84,239
-76% -$6.78M
TRI icon
266
Thomson Reuters
TRI
$42.8B
$2.05M 0.1%
46,346
+14,117
+44% +$661K
L icon
267
Loews
L
$23.9B
$2.05M 0.1%
53,163
+38,291
+257% +$1.56M
CTLT
268
DELISTED
CATALENT, INC.
CTLT
$2.04M 0.1%
+69,678
New +$2.1M
SFM icon
269
Sprouts Farmers Market
SFM
$8.13B
$2.04M 0.1%
75,648
+26,178
+53% +$804K
VTRS icon
270
Viatris
VTRS
$20.4B
$2.04M 0.1%
30,018
-12,595
-30% -$890K
AA icon
271
Alcoa
AA
$11.9B
$2.04M 0.1%
75,953
+21,620
+40% +$670K
NVS icon
272
Novartis
NVS
$297B
$2.03M 0.1%
23,060
+5,298
+30% +$486K
DHR icon
273
Danaher
DHR
$137B
$2.03M 0.1%
35,288
-35,661
-50% -$2.04M
WOLF icon
274
Wolfspeed
WOLF
$1.23B
$2.02M 0.1%
77,635
+65,445
+537% +$2.06M
GS icon
275
Goldman Sachs
GS
$300B
$2M 0.1%
9,577
-11,575
-55% -$2.36M

Similar funds

Cubist Systematic Strategies's Q2 2015 Portfolio in Review

As of Q2 2015, Cubist Systematic Strategies held 2,312 positions worth $2.05B, up 0.2% from $2.04B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Cubist Systematic Strategies's Q2 2015 filing shows 444 new, 666 increased, 682 reduced and 516 closed positions. Its largest new stake was Ultimate Software Group Inc: 29,148 shares worth $4.79M. The largest sale was Gilead Sciences, an estimated $10.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Cubist Systematic Strategies's largest Q2 2015 buy was Ultimate Software Group Inc: 29,148 shares worth $4.79M.
  • Cubist Systematic Strategies added most to Hilton Worldwide in Q2 2015, an estimated $17.5M increase.
  • Cubist Systematic Strategies's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $10.7M.
  • Cubist Systematic Strategies fully exited RTX Corp in Q2 2015, selling an estimated $7.16M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.8% of its $2.05B portfolio in Q2 2015.
  • Cubist Systematic Strategies opened 444 new positions and closed 516 in Q2 2015.
  • Cubist Systematic Strategies's portfolio value rose 0.2% quarter-over-quarter to $2.05B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2015, filed 14 Aug 2015.